ENDRA Life Sciences TAEUS De Novo Submission Advances to Next Stage of Review with FDA
NDRA Stock | USD 5.71 0.34 5.62% |
About 63% of ENDRA Life's investor base is looking to short. The analysis of overall sentiment of trading ENDRA Life Sciences stock suggests that many investors are alarmed at this time. The current market sentiment, together with ENDRA Life's historical and current headlines, can help investors time the market. In addition, many technical investors use ENDRA Life Sciences stock news signals to limit their universe of possible portfolio assets.
ENDRA |
ANN ARBOR, Mich., August 30, 2023 ENDRA Life Sciences Inc. , a pioneer of imaging technologies and Thermo Acoustic Enhanced UltraSound , announces that the Companys De Novo request for the TAEUS liver system has advanced to substantive review with the U.S. Food and Drug Administration . The TAEUS system is ENDRAs proprietary device that is intended to offer clinicians a tool for the non-invasive assessment of fatty liver tissue, as an aid in the management of patien
Read at finance.yahoo.com
ENDRA Life Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards ENDRA Life can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
ENDRA Life Fundamental Analysis
We analyze ENDRA Life's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ENDRA Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ENDRA Life based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Ratio
Current Ratio Comparative Analysis
ENDRA Life is currently under evaluation in current ratio category among its peers. Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
ENDRA Life Sciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ENDRA Life stock to make a market-neutral strategy. Peer analysis of ENDRA Life could also be used in its relative valuation, which is a method of valuing ENDRA Life by comparing valuation metrics with similar companies.
Peers
ENDRA Life Related Equities
BNR | Burning Rock | 16.01 | ||||
DRIO | DarioHealth Corp | 9.72 | ||||
STIM | Neuronetics | 4.17 | ||||
STRRP | Star Equity | 2.73 | ||||
SERA | Sera Prognostics | 1.81 | ||||
LAB | Standard Biotools | 1.10 | ||||
BDSX | Biodesix | 0.70 | ||||
INBS | Intelligent Bio | 1.84 | ||||
BIAFW | BioAffinity Technologies | 4.00 |
Complementary Tools for ENDRA Stock analysis
When running ENDRA Life's price analysis, check to measure ENDRA Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ENDRA Life is operating at the current time. Most of ENDRA Life's value examination focuses on studying past and present price action to predict the probability of ENDRA Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ENDRA Life's price. Additionally, you may evaluate how the addition of ENDRA Life to your portfolios can decrease your overall portfolio volatility.
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
CEOs Directory Screen CEOs from public companies around the world | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Stocks Directory Find actively traded stocks across global markets | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |